Compugen Q2 Revenues Fall, Loss Rises | GenomeWeb

NEW YORK, July 22 (GenomeWeb News) - Compugen on Wednesday reported a sharp decline in revenues and a higher net loss for the second quarter of 2004, as it continues implementing its plan to focus on its therapeutic protein pipeline.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.